Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

August 2015

Prior Authorization Required for Duexis and Vimovo

Beginning October 1, 2015, Harvard Pilgrim will require prior authorization for coverage of the combination non-steroidal anti-inflammatory drugs (NSAIDs) and acid-reducing therapies Duexis (ibuprofen/famotidine) and Vimovo (esomeprazole/naproxen) on the Premium formularies. These medications are not covered on the Value formularies.

On August 1, 2015, Harvard Pilgrim sent letters to members who have filled prescriptions for either of these agents in the past three months notifying them of the change. Harvard Pilgrim's NSAID-GI Combination Agents Clinical Coverage Criteria detail the requirements that must be met in order to obtain prior authorization, including:

  • Diagnosis of rheumatoid arthritis, osteoarthritis, or ankylosing spondylitis
  • Patient has at least one of the following risk factors for GI toxicity:
    1. Is over age 65
    2. Has a history of gastrointestinal (GI) event, including peptic ulcer, GI bleed, GI obstruction or GI perforation
    3. Is on high-dose NSAID therapy
    4. Is concurrently using aspirin (including low dose), corticosteroids, anticoagulants, selective serotonin reuptake inhibitors (SSRIs), or bisphosphonates
  • Patient has tried and failed therapy with simultaneous use of a NSAID or COX-2 inhibitor AND PPI or misoprostol.

Approvals will be valid for 12 months. To request prior authorization, please complete the NSAID-GI Combination Agents Medication Request Form and fax it to MedImpact Healthcare Systems at 888-807-6643.

For more information, please refer to the Pharmacy section of Harvard Pilgrim's provider website.

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


ICD-10 Transition & Paper Claims Submission


New Clinical Medical Policies

Medical Criteria for Inverted Nipple Repair

The Safe Storage and Disposal of Opioids

New HEDIS Measure:  Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM)

Prior Authorization Required for Duexis and Vimovo

Prior Authorization Required for Entresto

ICORE Healthcare Becoming Magellan Rx Pharmacy, LLC

Coordination of Care for Transgender Patients

Harvard Pilgrim’s EatRight Rewards Promotes Wellness


Bilateral Reimbursement

Update Coming to HPHConnect for Providers

Reminder: Save Time and Paper with Harvard Pilgrim’s Electronic Tools


Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator